A Biomimetic Cell Membrane-Coated Nanoreactor Reshapes ROS Homeostasis and Activates STING Pathway for Synergistic Chemodynamic–Immunotherapy
ACS Applied Materials & Interfaces · 12.11.2026
DOI: 10.1021/acsami.6c15847 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 12.11.2026. Verfasst von Waqas Ahmad und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Polymer Science and Engineering, University of Science and Technology of China, Hefei, Anhui230026, China. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Xi'an Jiaotong University, National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
The combination of chemodynamic therapy (CDT) and immunotherapy offers a promising therapeutic paradigm for advanced cancer treatment, yet its translation is largely hindered by inadequate intratumoral reactive oxygen species (ROS) production and the lack of a robust link between ROS-induced cytotoxicity and durable immune activation. To address these challenges, we herein engineer a multifunctional biomimetic nanoplatform (ZMGM) by encapsulating Mn2+ and glucose oxidase (GOX) within zeolitic imidazolate framework-8 (ZIF-8), followed by surface functionalization with 4T1 breast cancer cell membranes. This design integrates three synergistic functions: (1) GOX depletes glucose and generates hydrogen peroxide (H2O2) within the acidic tumor microenvironment; (2) the produced H2O2 fuels the Mn2+-mediated Fenton-like reaction to amplify ROS production; and (3) Mn2+ simultaneously serves as a potent stimulator of interferon genes (STING) agonist, triggering type-I interferon responses and promoting dendritic cell maturation. Meanwhile, the homologous cancer cell membrane coating endows ZMGM with specific tumor homing and enhanced tumor localization. Both in vitro and in vivo findings demonstrate that ZMGM not only efficiently eradicates primary tumors but also induces a systemic antitumor immune response, characterized by increased CD8+ T cell infiltration, that effectively suppresses distant metastatic lesions. Notably, the synergistic CDT–STING immunotherapy achieves a primary tumor inhibition rate of 84.22% without obvious systemic toxicity. This work provides a paradigm for rationally designing a single nanoplatform that bridges ROS-mediated cell killing and innate immune activation, offering a promising avenue for combating metastatic triple-negative breast cancer.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Polymer Science and Engineering, University of Science and Technology of China, Hefei, Anhui230026, China.
- School of Chemistry, State Key Laboratory of Fluorine & Nitrogen Chemicals, Institute of New Concept Sensors and Molecular Materials (INCSMM), Engineering Research Center of Energy Storage Materials and Devices, Ministr…
- School of Life Science and Technology, Northwestern Polytechnical University , No. 127 West Youyi Road, Xi'an710072, China.
- Department of Geriatric General Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi710004, China.
- Department of Medicinal Chemistry, Institute of Biochemistry, Samarkand State University, University Blvd. 15, Samarkand140104, Uzbekistan.
ORCID-Profile: Khurshed Bozorov, Yuanyuan Ji, Qinghao Zhou, Zhishen Ge
Förderung
- Xi'an Jiaotong University
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- Fundamental Research Funds for the Central Universities
- Key Research and Development Projects of Shaanxi Province
- Natural Science Basic Research Program of Shaanxi Province
- National Ten Thousand Talent Program
Zitieren
APA
Ahmad, W., Ashraf, G., Sajjad, W., Shams, S., Li, C., Bozorov, K., Ji, Y., Dutta, D., Zhou, Q., & Ge, Z. (2026). A Biomimetic Cell Membrane-Coated Nanoreactor Reshapes ROS Homeostasis and Activates STING Pathway for Synergistic Chemodynamic–Immunotherapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c15847
Vancouver
Ahmad W, Ashraf G, Sajjad W, Shams S, Li C, Bozorov K, et al. A Biomimetic Cell Membrane-Coated Nanoreactor Reshapes ROS Homeostasis and Activates STING Pathway for Synergistic Chemodynamic–Immunotherapy. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c15847
BibTeX
@article{Ahmad2026,
author = {Ahmad, Waqas and Ashraf, Ghazala and Sajjad, Wasim and Shams, Saira and Li, Cheng and Bozorov, Khurshed and Ji, Yuanyuan and Dutta, Debabrata and Zhou, Qinghao and Ge, Zhishen},
title = {A Biomimetic Cell Membrane-Coated Nanoreactor Reshapes ROS Homeostasis and Activates STING Pathway for Synergistic Chemodynamic–Immunotherapy},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c15847}
}
EUVIMED